Valens Announces Guidance for Record Q3 2019 Revenue and Participation in Live Investor Webcast on September 12th
Valens GroWorks Corp. (TSXV:VGW, OTCQX:VGWCF) (the “Company” or “Valens”), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab is pleased to announce revenue guidance for the recently completed third quarter 2019 in the range of $16 million – $17 million, a significant increase over its second quarter 2019 revenue of $8.8 million.
Record Third Quarter 2019 Revenue Guidance
The Company expects to report that it has extracted over 26,000 kilograms of cannabis and hemp biomass in the third quarter of 2019. This represents a significant ramp in extraction volumes compared with the 8,547 kilograms of dried cannabis and hemp biomass it processed in the second quarter of 2019, driven by the build out of the Company’s ethanol extraction capabilities and increasing volumes from our new and existing customers.
Jeffrey Fallows, President, said “We continue to see a significant ramp up in volumes month over month with August seeing almost 50% of the volumes in the third quarter. That pace has continued to accelerate into September as we look to fill our existing capacity on a run-rate basis in the next 6 months.”
Tyler Robson, CEO, commented, “Our 425,000 kilograms of extraction capacity enabled us to process record volumes in the third quarter of 2019, making us the largest processor of cannabis and hemp biomass in Canada and driving significant revenue growth for the Company. We continue to execute on delivering the highest quality extraction services to our customers as the demand for distillates ramps up in anticipation of edibles and concentrates hitting the shelves later this year. As more companies begin to harvest large volumes of licensed industrial hemp, we also expect demand for hemp extraction, processing and CBD-infused product formulation to accelerate. To meet this demand, we have developed what we believe is a first-of-its-kind ethanol extraction line that utilizes equipment from around the world to deliver high quality distillate to our customers. Looking to the future, and to position us to keep pace with the growth of the industry, we are also expanding our 425,000 kilogram capacity to over 1,000,000 kilograms in the first half of 2020.”
Live Investor Webcast
The Company is pleased to also announce its participation on VirtualInvestorConferences.com on September 12th, at 2:00 PM EST, for a live investor presentation.
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Recent Company Highlights
- Increased its annual extraction capacity to 425,000 kilograms with plans to surpass 1,000,000 kilograms per annum.
- Added to The Cannabis ETF which trades on the New York Stock Exchange.
- Commenced trading on the TSX Venture Exchange and on the OTCQX best market in the U.S.
- Valens opened new offices in Toronto as it gears for geographical expansion.
- Reported record $8.8 Million in Revenue and Adjusted EBITDA of $2.0 Million in the second quarter of fiscal 2019.
- Expanded its extraction partnership with Tilray Canada Ltd. Increasing the volume of extraction services and has added an option to provide contract manufacturing services.
Learn more about the event at www.VirtualInvestorConferences.com.
About Valens GroWorks
Valens GroWorks Corp. (TSXV:VGW, OTCQX:VGWCF) is a multi-licensed, vertically-integrated cannabis company focused on being the partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation and white label product development. Valens is the largest third-party extraction Company in Canada with an annual capacity of 425,000 kg of dried cannabis and hemp biomass at our purpose-built facility in Kelowna, British Columbia which is in the process of becoming European Union (EU) Good Manufacturing Practices (GMP) compliant. Additionally, our subsidiary Valens Labs is a Health Canada licensed ISO 17025 accredited cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant-Based Science. For more information, please visit http://valensgroworks.com. The Company’s investor deck can be found specifically at http://valensgroworks.com/investors/
Notice regarding Forward Looking Statements
This news release contains certain “forward-looking statements” within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as “anticipates”, “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed”, “positioned” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Corporation is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Cannabis - Will The Fortune 500 Join The Party?
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.
Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.
The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising
Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.
In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.
Gage Cannabis Announces Exclusive Partnership With Blue River to Bring Award-Winning Cannabis Extracts to Michigan
Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.